Stockreport

Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024 [Yahoo! Finance]

Protalix BioTherapeutics, Inc. (DE)  (PLX) 
PDF American:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary P [Read more]